Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.56
+0.11501.01%
Volume:604.41K
Turnover:6.95M
Market Cap:880.90M
PE:-4.12
High:11.72
Open:11.28
Low:11.09
Close:11.44
Loading ...
Mar 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 04, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2020

Major Issues Report

8-K - Current report
Oct 26, 2020

Major Issues Report

8-K - Current report
Oct 14, 2020

Major Issues Report

8-K - Current report
Oct 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 14, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 03, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 24, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 23, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 21, 2020

Correspondence

CORRESP [Cover] - Correspondence